I am a post-doctoral researcher at the Division of Translational Alzheimer Neurobiology since 2012. I am very curious person and challenge-driven. With a solid scientific background in molecular biology and epigenetics, I have a strong interest in translational research and in understanding the molecular basis of human pathologies with the aim to find new therapies and diagnostic tools.
PhD in Medical Biology, University of Montpellier, France, 2011.
MSc in Medical Biotechnology, University of Bari, Italy, 2006.
BSc in Medical and Pharmaceutical Biotechnology, University of Bari, Italy, 2004.
My research at the Division of Translational Alzheimer Neurobiology focuses on understanding epigenetic and transcriptional alterations related to the presence of beta-amyloid (Aβ) in Alzheimer’s disease. I'm also interested in how Aβ modulates the cholinergic system and how Aβ is internalised by neuronal cells.
By unveiling the physiological and pathological roles of Aβ, my research aims at an improved understanding of the molecular mechanisms that underlie Alzheimer’s Disease, with the goal to find new biomarkers for early diagnosis, as well as ideas for new treatment strategies.
Academic honors, awards and prizes
2012-2016 Research grants from Tore Nilson’s Foundation for Medical Research; Karolinska Institute Research Foundations; O.E. and Edla Johansson’s Scientific Foundation; Foundation for Geriatric Diseases at Karolinska Institute; Sigurd and Elsa Golje’s Memorial Foundation; Dementia Association; Foundation for Old Servants; Gun and Bertil Stohne’s Foundation.
'Epigenetic modifications in Alzheimer’s disease: effects of βamyloid exposure’. AAIC (Alzheimer’s Association International Conference), Copenhagen, Denmark. July 2014.